Level of instruction: Intermediate
Intended Audience: Clinical laboratory technologists and technicians, and other health care personnel who have an interest in this subject matter. This course is also appropriate for clinical laboratory science students and pathology residents.
Author Information: Lillian Mundt, EdD, CLS(NCA)SpH, MT(ASCP)SH is an Associate Professor and Acting Department Chair in the Department of Clinical Laboratory Sciences at Rosalind Franklin University. She is responsible for various courses in the graduate programs as well as departmental administration.
She received her Bachelor of Arts degree in Medical Technology from Aurora College, Aurora, Illinois Her graduate work was completed at Governor's State University, University Park, Illinois, from which she received her Master of Health Science in Allied Health Professions Education; her doctorate in Educational Leadership was earned in 2007 from the University of Phoenix.
Her work experience includes a position as a medical technologist in hematology for 30 plus years at Hinsdale Hospital, Department of Pathology, where she still works on an as-needed basis. Lillian also taught at Hinsdale Hospital School of Medical Technology from 1989 until it closed in 1994.
Reviewer Information: Catherine Hart, MT(ASCP) received her Bachelor of Science degree in Medical Technology at Marquette University. She has been a Medical Technologist at Lake Forest Hospital in Illinois for twenty years and is currently a Senior Technologist, with responsibilities in Blood Bank, Hematology, and the competency and proficiency testing program of the laboratory. Ms. Hart has been the adjunct Blood Bank instructor for the Clinical Laboratory Sciences program at Rosalind Franklin University since 2001 and is the Blood Bank clinical instructor at Lake Forest Hospital. As of May 2007, she joined the RFUMS CLS appointed faculty and is teaching the Hematology and Blood Bank courses.
Course Description: This course defines and discusses in depth the disorder, beta thalassemia. Topics include: Clinical manifestations, the genetics of beta thalassemia, and laboratory findings.